For the year ending 2025-12-31, MIRM made $521,312K in revenue. -$23,363K in net income. Net profit margin of -4.48%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 521,312 | |||
| Cost of sales | 100,240 | |||
| Research and development | 186,178 | |||
| Selling, general and administrative | 257,030 | |||
| Total operating expenses | 543,448 | |||
| Loss from operations | -22,136 | |||
| Interest income | 12,727 | |||
| Interest expense | 14,389 | |||
| Loss from termination of revenue interest purchase agreement | 0 | |||
| Other income (expense), net | 2,371 | |||
| Loss before provision for income taxes | -21,427 | |||
| Provision for income taxes | 1,936 | |||
| Net loss | -23,363 | |||
| Basic EPS | -0.47 | |||
| Diluted EPS | -0.47 | |||
| Basic Average Shares | 50,198,304 | |||
| Diluted Average Shares | 50,198,304 | |||
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)